Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis

2016 ◽  
Vol 31 (11) ◽  
pp. 1851-1859 ◽  
Author(s):  
Raoel Maan ◽  
Remziye Zaim ◽  
Adriaan J van der Meer ◽  
Jordan J Feld ◽  
Heiner Wedemeyer ◽  
...  
Keyword(s):  
Antiviral Therapy ◽  
Hepatic Fibrosis ◽  
Real World ◽  
Medical Costs ◽  
Hcv Infection ◽  
Chronic Hcv Infection ◽  
Chronic Hcv

scholarly journals Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis

2015 ◽  
Vol 18 (7) ◽  
pp. A624
Author(s):  
R Maan ◽  
R Zaim ◽  
A van der Meer ◽  
J Feld ◽  
H Wedemeyer ◽  
...  
Keyword(s):  
Antiviral Therapy ◽  
Hepatic Fibrosis ◽  
Real World ◽  
Medical Costs ◽  
Hcv Infection ◽  
Chronic Hcv Infection ◽  
Chronic Hcv

Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis

2014 ◽  
Vol 61 (3) ◽  
pp. 482-491 ◽  
Author(s):  
Raoel Maan ◽  
Adriaan J. van der Meer ◽  
Bettina E. Hansen ◽  
Jordan J. Feld ◽  
Heiner Wedemeyer ◽  
...  
Keyword(s):  
Hepatic Fibrosis ◽  
Hcv Infection ◽  
Chronic Hcv Infection ◽  
Chronic Hcv

Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses

2007 ◽  
Vol 14 (5) ◽  
pp. 318-329 ◽  
Author(s):  
Vinodh Pillai ◽  
William M. Lee ◽  
Dwain L. Thiele ◽  
Nitin J. Karandikar
Keyword(s):  
T Cell ◽  
Antiviral Therapy ◽  
T Cell Responses ◽  
Cd8 T Cell ◽  
Hcv Infection ◽  
Cell Responses ◽  
Chronic Hcv Infection ◽  
Chronic Hcv

Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment

2017 ◽  
Vol 63 (2) ◽  
pp. 486-492 ◽  
Author(s):  
Justin Chan ◽  
Neliswa Gogela ◽  
Hui Zheng ◽  
Sara Lammert ◽  
Tokunbo Ajayi ◽  
...  
Keyword(s):  
Antiviral Therapy ◽  
Liver Stiffness ◽  
Post Treatment ◽  
Hcv Infection ◽  
Direct Acting Antiviral ◽  
Chronic Hcv Infection ◽  
Chronic Hcv ◽  
Direct Acting

Antiviral therapy of chronic HCV infection in kidney transplant recipient

2019 ◽  
Vol 21 (2) ◽  
pp. 191-198
Author(s):  
M.L. Zubkin ◽  
◽  
I.G. Kim ◽  
O.S. Arisheva ◽  
N.A. Tomilina ◽  
...  
Keyword(s):  
Transplant Recipient ◽  
Antiviral Therapy ◽  
Kidney Transplant ◽  
Kidney Transplant Recipient ◽  
Hcv Infection ◽  
Chronic Hcv Infection ◽  
Chronic Hcv

scholarly journals Hepatocellular carcinoma after direct-acting antiviral therapy for chronic HCV infection: Is it a real risk?

IDCases ◽  
2018 ◽  
Vol 14 ◽  
pp. e00450 ◽  
Author(s):  
Cátia Dias ◽  
Filipa Duarte-Ribeiro ◽  
Sara Pipa ◽  
Ana Rita Barbosa ◽  
Margarida Mota ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Antiviral Therapy ◽  
Hcv Infection ◽  
Direct Acting Antiviral ◽  
Real Risk ◽  
Chronic Hcv Infection ◽  
Chronic Hcv ◽  
Direct Acting

scholarly journals Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0135645 ◽  
Author(s):  
Albert Do ◽  
Yash Mittal ◽  
AnnMarie Liapakis ◽  
Elizabeth Cohen ◽  
Hong Chau ◽  
...  
Keyword(s):  
Real World ◽  
Hcv Infection ◽  
Care Cascade ◽  
Chronic Hcv Infection ◽  
Chronic Hcv
Sign in / Sign up

Export Citation Format

Share Document